Metagenomi Inc
MGX2.285USD
+0.035+1.56%
交易中 （美東）報價延遲15分鐘
85.42M總市值
虧損本益比TTM
關於 Metagenomi Inc 公司
Metagenomi, Inc. 是一家精準基因醫學公司。該公司專注於利用其全面的宏基因組學衍生工具箱爲患者開發治癒性療法。其多樣化和模塊化的基因組編輯工具箱旨在精確靶向人類基因組中的任何位點。其全面的基因組編輯工具箱包括可編程核酸酶、鹼基編輯器以及 RNA 和 DNA 介導的整合系統，包括主要編輯系統和成簇的規則間隔短迴文重複序列 (CRISPR) 相關轉座酶 (CAST)。該公司還開發了一個廣泛而模塊化的基因組編輯系統工具箱，使其能夠以位點特異性的方式與人類基因組相互作用，其中每個工具都可以與特定的疾病目標相匹配。其平臺使其能夠快速有效地找到、篩選和選擇具有最高靶向性、特異性和效率的工具，以便將它們開發成基因醫學。
公司簡介
公司代碼MGX
公司名稱Metagenomi Inc
上市日期Feb 09, 2024
CEODr. Brian C. Thomas, Ph.D.
員工數量202
證券類型Ordinary Share
年結日Feb 09
公司地址5959 Horton St
城市EMERYVILLE
上市交易所NASDAQ Global Select Consolidated
國家United States of America
郵編94608
電話15108714880
網址https://metagenomi.co/
公司代碼MGX
上市日期Feb 09, 2024
CEODr. Brian C. Thomas, Ph.D.
公司高階主管
名稱
名稱/職務
職務
持股
持股變動
Dr. Brian C. Thomas, Ph.D.
Dr. Brian C. Thomas, Ph.D.
Chairman of the Board, Chief Executive Officer, Co-Founder
Chairman of the Board, Chief Executive Officer, Co-Founder
2.37M
-0.45%
Dr. Jian Irish, Ph.D.
Dr. Jian Irish, Ph.D.
President, Chief Operating Officer, Director
President, Chief Operating Officer, Director
579.04K
-1.09%
Dr. Sarah B. Noonberg, M.D., Ph.D.
Dr. Sarah B. Noonberg, M.D., Ph.D.
Chief Medical Officer
Chief Medical Officer
109.14K
-4.58%
,
,
Senior Vice President, Head of Legal, Compliance Officer and Corporate Secretary
Senior Vice President, Head of Legal, Compliance Officer and Corporate Secretary
--
--
Dr. Juergen Eckhardt, M.D.
Dr. Juergen Eckhardt, M.D.
Independent Director
Independent Director
--
--
Ms. Pamela M. (Pam) Wapnick
Ms. Pamela M. (Pam) Wapnick
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Eric H. Bjerkholt
Mr. Eric H. Bjerkholt
Independent Director
Independent Director
--
--
Dr. Willard H. Dere, M.D.
Dr. Willard H. Dere, M.D.
Lead Independent Director
Lead Independent Director
--
--
名稱
名稱/職務
職務
持股
持股變動
Dr. Brian C. Thomas, Ph.D.
Dr. Brian C. Thomas, Ph.D.
Chairman of the Board, Chief Executive Officer, Co-Founder
Chairman of the Board, Chief Executive Officer, Co-Founder
2.37M
-0.45%
Dr. Jian Irish, Ph.D.
Dr. Jian Irish, Ph.D.
President, Chief Operating Officer, Director
President, Chief Operating Officer, Director
579.04K
-1.09%
Dr. Sarah B. Noonberg, M.D., Ph.D.
Dr. Sarah B. Noonberg, M.D., Ph.D.
Chief Medical Officer
Chief Medical Officer
109.14K
-4.58%
,
,
Senior Vice President, Head of Legal, Compliance Officer and Corporate Secretary
Senior Vice President, Head of Legal, Compliance Officer and Corporate Secretary
--
--
Dr. Juergen Eckhardt, M.D.
Dr. Juergen Eckhardt, M.D.
Independent Director
Independent Director
--
--
Ms. Pamela M. (Pam) Wapnick
Ms. Pamela M. (Pam) Wapnick
Chief Financial Officer
Chief Financial Officer
--
--
收入明細
暫無數據
暫無數據
業務
地區
暫無數據
股東統計
更新時間: 5月17日 週六
更新時間: 5月17日 週六
持股股東
股東類型
持股股東
持股股東
佔比
Bayer HealthCare LLC
10.84%
Thomas (Brian C)
6.33%
Humboldt Capital, LLC
5.07%
The Vanguard Group, Inc.
3.90%
BlackRock Institutional Trust Company, N.A.
3.78%
Other
70.08%
持股股東
持股股東
佔比
Bayer HealthCare LLC
10.84%
Thomas (Brian C)
6.33%
Humboldt Capital, LLC
5.07%
The Vanguard Group, Inc.
3.90%
BlackRock Institutional Trust Company, N.A.
3.78%
Other
70.08%
股東類型
持股股東
佔比
Corporation
15.91%
Individual Investor
12.29%
Investment Advisor
11.49%
Investment Advisor/Hedge Fund
5.46%
Hedge Fund
4.68%
Venture Capital
2.97%
Sovereign Wealth Fund
0.96%
Research Firm
0.78%
Bank and Trust
0.08%
Other
45.38%
機構持股
更新時間: 7月1日 週二
更新時間: 7月1日 週二
報告期間
機構數
持股數
持股佔比
持股變動
2025Q2
158
20.59M
55.08%
-7.29M
2025Q1
157
20.44M
54.67%
-7.64M
2024Q4
143
21.51M
57.48%
-2.78M
2024Q3
116
23.74M
63.40%
-1.13M
2024Q2
94
26.05M
69.54%
+4.67M
2024Q1
65
26.68M
71.20%
+16.22M
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
Bayer HealthCare LLC
4.05M
10.84%
--
--
Sep 30, 2024
Thomas (Brian C)
2.37M
6.33%
-10.79K
-0.45%
Jun 06, 2025
Humboldt Capital, LLC
1.90M
5.07%
--
--
Apr 14, 2025
The Vanguard Group, Inc.
1.46M
3.9%
+188.80K
+14.88%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
1.41M
3.78%
+62.14K
+4.59%
Mar 31, 2025
Bernales (Sebastian Ph.D.)
1.17M
3.14%
--
--
Apr 14, 2025
PFM Health Sciences, LP
885.80K
2.37%
--
--
Mar 31, 2025
Geode Capital Management, L.L.C.
619.57K
1.66%
+32.15K
+5.47%
Mar 31, 2025
Sozo Ventures LLC
581.58K
1.56%
--
--
Mar 31, 2025
Irish (Jian)
579.04K
1.55%
-6.39K
-1.09%
Jun 06, 2025
查看更多
持股ETF
更新時間: 8月2日 週六
更新時間: 8月2日 週六
機構名稱
佔比
iShares Micro-Cap ETF
0.01%
iShares Russell 2000 Value ETF
0%
Proshares Ultra Russell 2000
0%
ProShares Hedge Replication ETF
0%
Global X Russell 2000 ETF
0%
Schwab U.S. Small-Cap ETF
0%
iShares Russell 2000 ETF
0%
ProShares UltraPro Russell2000
0%
iShares Russell 2000 Growth ETF
0%
iShares Micro-Cap ETF
佔比0.01%
iShares Russell 2000 Value ETF
佔比0%
Proshares Ultra Russell 2000
佔比0%
ProShares Hedge Replication ETF
佔比0%
Global X Russell 2000 ETF
佔比0%
Schwab U.S. Small-Cap ETF
佔比0%
iShares Russell 2000 ETF
佔比0%
ProShares UltraPro Russell2000
佔比0%
iShares Russell 2000 Growth ETF
佔比0%
分紅派息
近5年累計派現
0.00
美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據
拆合股
公告日期
類型
比率
暫無數據
公告日期
類型
比率
暫無數據
